HPV vaccines in immunocompromised women and men

被引：61

作者：

Palefsky, Joel M.

Gillison, Maura L.

Strickler, Howard D.

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD USA

[3] Albert Einstein Coll Med, New York, NY USA

来源：

VACCINE | 2006年 / 24卷

关键词：

HIV; HPV; vaccines;

D O I：

10.1016/j.vaccine.2006.05.120

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

HIV-positive as well as other immunocompromised women and men have increased risk of human papillomavirus (HPV)-associated anogenital and oral cancers. The effectiveness of a HPV vaccine to reduce the incidence of these tumors in immunocompromised individuals may depend on several factors, including the effects of immunocompromise on the response to vaccination, the extent of prior infection with the HPV types included in the vaccine, whether immunocompromised women and men have tumors that contain types of HPV not in the vaccines more often than the general population, and whether or not immunization occurs before immunocompromise is severe. Clinical studies are needed to determine HPV vaccine safety and effectiveness in different populations of immunocompromised women and men. (c) 2006 Elsevier Ltd. All rights reserved.

引用

收藏

页码：140 / 146

页数：7

相关论文

共 38 条

[1] Cancer risk following organ transplantation:: a nationwide cohort study in Sweden [J].

Adami, J ;

Gäbel, H ;

Lindelöf, B ;

Ekström, K ;

Rydh, B ;

Glimelius, B ;

Ekbom, A ;

Adami, HO ;

Granath, F .

BRITISH JOURNAL OF CANCER, 2003, 89 (07) :1221-1227

[2] Vaccinations for adult solid organ transplant recipient: Current recommendations [J].

Ballout, A ;

Goffin, E ;

Yombi, JC ;

Vandercam, B .

TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) :2826-2827

[3] HIV-associated anal cancer - Has highly active antiretroviral therapy reduced the incidence or improved the outcome? [J].

Bower, M ;

Powles, T ;

Newsom-Davis, T ;

Thirlwell, C ;

Stebbing, J ;

Mandalia, S ;

Nelson, M ;

Gazzard, B .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (05) :1563-1565

[4] Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals [J].

Cameron, JE ;

Snowhite, IV ;

Chaturvedi, AK ;

Hagensee, ME .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (03) :431-438

[5] The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults [J].

Cameron, JE ;

Mercante, D ;

O'Brien, M ;

Gaffga, AM ;

Leigh, JE ;

Fidel, PL ;

Hagensee, ME .

SEXUALLY TRANSMITTED DISEASES, 2005, 32 (11) :703-709

[6] Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].

Clifford, GM ;

Polesel, J ;

Rickenbach, M ;

Dal Maso, L ;

Keiser, O ;

Kofler, A ;

Rapiti, E ;

Levi, F ;

Jundt, G ;

Fisch, T ;

Bordoni, A ;

De Weck, D ;

Franceschi, S .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432

[7] Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer [J].

Daling, JR ;

Madeleine, MM ;

Johnson, LG ;

Schwartz, SM ;

Shera, KA ;

Wurscher, MA ;

Carter, JJ ;

Porter, PL ;

Galloway, DA ;

McDougall, JK .

CANCER, 2004, 101 (02) :270-280

[8] Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome [J].

Frisch, M ;

Biggar, IJ ;

Goedert, JJ .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) :1500-1510

[9] Sexually transmitted infection as a cause of anal cancer [J].

Frisch, M ;

Glimelius, B ;

vandenBrule, AJC ;

Wohlfahrt, J ;

Meijer, CJLM ;

Walboomers, JMM ;

Goldman, S ;

Svensson, C ;

Adami, HO ;

Melbye, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1350-1358

[10] Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity [J].

Gillison, ML .

SEMINARS IN ONCOLOGY, 2004, 31 (06) :744-754

← 1 2 3 4 →